Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Vikram A. Rajadnya"'
Autor:
Vikram A. Rajadnya, Diya Amol More
Publikováno v:
Biomedical and Pharmacology Journal. 14:815-821
Background: Antidiabetic drugs have to be taken for life , in majority of the patients. Price differences can lead to huge economic burden on the patients of diabetes, especially when cost considerations are not undertaken by the healthcare provider
Autor:
Vikram A. Rajadnya, Diya Amol More
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 10:830
Background: The objective was to study the annual cost of each of the four important brands of insulin glargine available in India and to study the comparative annual cost of all the four brands.Methods: Four most commonly prescribed brands of insuli
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 8:2237
Background: The main objective of the Maharashtra Health Systems Development Project (MHSDP) is to enhance the quality of care by improving health care; in the hospitals, in the state. Improvement in the prescribing practice of resident doctors worki
Autor:
Vikram A. Rajadnya
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 8:1734
Background: Antiplatelet drugs need to be prescribed lifelong, for most of the selected patients, once started. Price disparity can lead to large financial stress on the patients, especially when cost related aspects are not paid heed to by the presc
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 8:1514
Background: Hypolipidemic drugs need to be prescribed lifelong for most of the selected patients, once started. Price variation can lead to huge financial strain on the patients, especially when cost associated issues are not considered by the prescr
Autor:
Rahul Bhalsinge, Revati Kothari, Sayan Das, Vikram A. Rajadnya, A. V. Tilak, Siddhi Raveendran
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 8:1563
Background: The International Association for Study of pain, has defined pain as actual or potential tissue damage or described in terms of such damage. But the burden of unwanted side effects with current regimens are high. To explore the potential
Autor:
Sheena R. Bedi, Vikram A. Rajadnya
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 8:1377
Background: Antihypertensive drugs have to be taken lifelong, after initiation of the treatment. Price variation can lead to huge economic burden on the patients of hypertension, especially when cost considerations are not undertaken by the prescribi
Autor:
Siddhi Raveendran, Teja Deshpande, Sayan Das, Abhijeet V. Tilak, Vikram A. Rajadnya, Revati Kothari
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 8:1393
Background: Metabolic syndrome is described as the clustering of obesity, aberrant glucose metabolism, dyslipidemia and hypertension. A characteristic pattern, termed diabetic dyslipidemia, consists of low HDL, increased triglycerides and postprandia
Autor:
B. T. Rane, Chaitra V. Rajadnya, Suhas H. Patil, Rahul Maruti Manjare, Abhijeet V. Tilak, Vikram A. Rajadnya
Publikováno v:
International Journal of Community Medicine and Public Health. 2:180
Background: This study was intended to evaluate perception of the young adult obese men towards weight training as a proper and useful modality as compared to walking. Methods: The study was a questionnaire based and conducted in a weight management